Book contents
- Seminars in Clinical Psychopharmacology
- College Seminars Series
- Seminars in Clinical Psychopharmacology
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Editor’s Note on Nomenclature
- Neuroscience-Based Nomenclature Glossary
- Abbreviations
- Part 1 Basic Science and General Principles
- Part 2 Psychopharmacology of the Main Psychotropic Drug Groups
- Chapter 7 Drugs to Treat Depression
- Chapter 8 Drugs to Treat Anxiety and Insomnia
- 8.1 Introduction
- 8.2 Overview of the Presumed Neuropsychobiology of Anxiety Disorders
- 8.3 General Considerations in Pharmacological Treatment of Anxiety Disorders
- 8.4 Benzodiazepine Hypnotics and Anxiolytics
- 8.5 ‘Z-Drugs’ in the Treatment of Insomnia
- 8.6 Other Medications Used in the Treatment of Insomnia
- 8.7 Antidepressant Drugs to Treat Anxiety Disorders
- 8.8 Antipsychotic Drugs to Treat Anxiety Disorders
- 8.9 Pregabalin and Other Gabapentinoids
- 8.10 Buspirone and Related Azapirone Medications
- 8.11 Beta Blockers (β-Blockers)
- 8.12 Pathways to Improving Treatments for Anxiety Disorders
- Contents
- Chapter 9 Drugs to Treat Schizophrenia and Psychosis (Dopamine Antagonists and Partial Agonists Other Than Clozapine)
- Chapter 10 Clozapine
- Chapter 11 Lithium
- Chapter 12 Anticonvulsants for Mental Disorders: Valproate, Lamotrigine, Carbamazepine and Oxcarbazepine
- Chapter 13 Drugs to Treat Attention Deficit Hyperactivity Disorder (ADHD)
- Chapter 14 Drugs to Treat Dementia
- Chapter 15 Drugs to Treat Substance Use Disorders
- Chapter 16 Electroconvulsive Therapy and Neuromodulation Therapies
- Part 3 Specific Therapeutic Areas
- Index
Contents
from Chapter 8 - Drugs to Treat Anxiety and Insomnia
Published online by Cambridge University Press: 29 May 2020
- Seminars in Clinical Psychopharmacology
- College Seminars Series
- Seminars in Clinical Psychopharmacology
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Editor’s Note on Nomenclature
- Neuroscience-Based Nomenclature Glossary
- Abbreviations
- Part 1 Basic Science and General Principles
- Part 2 Psychopharmacology of the Main Psychotropic Drug Groups
- Chapter 7 Drugs to Treat Depression
- Chapter 8 Drugs to Treat Anxiety and Insomnia
- 8.1 Introduction
- 8.2 Overview of the Presumed Neuropsychobiology of Anxiety Disorders
- 8.3 General Considerations in Pharmacological Treatment of Anxiety Disorders
- 8.4 Benzodiazepine Hypnotics and Anxiolytics
- 8.5 ‘Z-Drugs’ in the Treatment of Insomnia
- 8.6 Other Medications Used in the Treatment of Insomnia
- 8.7 Antidepressant Drugs to Treat Anxiety Disorders
- 8.8 Antipsychotic Drugs to Treat Anxiety Disorders
- 8.9 Pregabalin and Other Gabapentinoids
- 8.10 Buspirone and Related Azapirone Medications
- 8.11 Beta Blockers (β-Blockers)
- 8.12 Pathways to Improving Treatments for Anxiety Disorders
- Contents
- Chapter 9 Drugs to Treat Schizophrenia and Psychosis (Dopamine Antagonists and Partial Agonists Other Than Clozapine)
- Chapter 10 Clozapine
- Chapter 11 Lithium
- Chapter 12 Anticonvulsants for Mental Disorders: Valproate, Lamotrigine, Carbamazepine and Oxcarbazepine
- Chapter 13 Drugs to Treat Attention Deficit Hyperactivity Disorder (ADHD)
- Chapter 14 Drugs to Treat Dementia
- Chapter 15 Drugs to Treat Substance Use Disorders
- Chapter 16 Electroconvulsive Therapy and Neuromodulation Therapies
- Part 3 Specific Therapeutic Areas
- Index
- Type
- Chapter
- Information
- Seminars in Clinical Psychopharmacology , pp. 268 - 269Publisher: Cambridge University PressPrint publication year: 2020